SGLT2-i reduces both systolic blood pressure (SBP) and diastolic blood pressure (DBP) across multiple trials and meta-analyses with reductions up to 8.6/4.3 mmHg, depending on the agent, dose and population studied
PwC's 2026 GLP-1 Usage & Attitudes Survey, drawing on 3,000-plus respondents, found that 44 percent of current GLP-1 users are buying more fresh produce, 35 percent more packaged protein, and 34 percent more fresh protein
Aunque un parche sea solo suplementos, los riesgos existen
Temporary treatment rarely produces permanent lifestyle change without the neurobiological support the medication provides
Storage requirements: Check whether you prefer a shelf-stable supplement or one that requires refrigeration, based on your lifestyle